LCTITAN: Beneficiary of Strong demands of Packaging, Mask and Glove's raw materials (Davidtslim)Author: davidtslim
Highlights:
Read the news below:
Company Background Olefins and the base stocks from which the polyolefins are produced. Polyethylene and polypropylene can be said to be the most widely used plastic raw materials from which a very wide range of consumer and industrial products are produced. In FY18-19, polyolefins accounted for approximately 80% of the total revenue generated by the Group.
If you interested on my analysis report, please contact me at davidlimtsi3@gmail.com You can get my latest update on share analysis at Telegram Channel ==> https://t.me/davidshare Disclaimer: This writing is based on my own assumptions and estimations. It is strictly for sharing purpose, not a buy or sell call of the company and the contents of this report should not be considered as professional financial investment advises or buy/sell recommendations. I strongly encourage you to do your own research and take independent financial advice from a professional before you proceed to invest. I make no representations as to the accuracy, completeness, correctness, suitability, or validity of any information on my report and will not be liable for any errors, omissions, or delay in this information or any losses and damages arising from its display or usage. All users should read the posts and analysis the information at their own risk and we shall not be held liable for any losses and damages.
Labels: LCTITAN NOVA: An Expanding Healthcare OBM player with high profit margin (Davidtslim)Author: davidtslim Summary:
2020 I am focusing more on gloves and healthcare stocks which I still heavy on glove stocks so far. Some of Nova Nova sanitizer products.
If you interested on my analysis report, please contact me at davidlimtsi3@gmail.com
You can get my latest update on share analysis at Telegram Channel ==> https://t.me/davidshare
This writing is based on my own assumptions and estimations. It is strictly for sharing purpose, not a buy or sell call of the company and the contents of this report should not be considered as professional financial investment advises or buy/sell recommendations. I strongly encourage you to do your own research and take independent financial advice from a professional before you proceed to invest. I make no representations as to the accuracy, completeness, correctness, suitability, or validity of any information on my report and will not be liable for any errors, omissions, or delay in this information or any losses and damages arising from its display or usage. All users should read the posts and analysis the information at their own risk and we shall not be held liable for any losses and damages. Labels: NOVA Samchem – Beneficiary of Raw Chemical Material supply to support healthcare industry (Davidtslim)Author: davidtslim See the extract from Samchem Annual report 2019 as figure below
Source: Annual Report 2019 Highlights:
Catalysts:
Revenue and Profit Margin: Samchem’s revenue has shown increment from 2016 (around 602m) to 1.05B in 2019 as shown in the Figure 1. This is more than 50% increment over 4 years time. As long as the company can improve its profit margin by 1-2%, the net profit improvement year-on-year will be quite significant.
|